Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube

Neuroscience CE Activities

Neuroscience blog

View Details

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.  
  • Neuroscience
  • Blog
DOWNLOAD
View Details

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.
  • Neuroscience
  • Blog
DOWNLOAD

RMEI DECISION SUPPORT AIDS

View Details

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
  • Neuroscience
  • Decision Support Aid
DOWNLOAD
View Details

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
  • Neuroscience, Psychiatry
  • Decision Support Aid
DOWNLOAD

LATEST NEUROSCIENCE ARTICLES

RSS Latest Neuroscience Articles
  • Clearing the Smoke on Fossil Fuels — The Health Imperative for a Countermarketing Campaign April 24, 2025
    As the fossil-fuel industry continues to obstruct efforts to curtail pollution from its products, the health community should use strategies that have been effective in fighting other health-harming industries.
    Linda Rudolph, Vishnu Laalitha Surapaneni
  • Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy April 24, 2025
    A comparison of clinical outcomes in 39 patients treated with atidarsagene autotemcel, a hematopoietic stem-cell–based gene therapy, with those of untreated patients showed a strong treatment effect over the long term.
    Francesca Fumagalli, Valeria Calbi, Vera Gallo, Alberto Andrea Zambon, Salvatore Recupero, Francesca Ciotti, Marina Sarzana, Maddalena Fraschini, Stefano Scarparo, Fabiola De Mattia, Simona Miglietta, Clelia Pierini, Matias Soncini, Francesco Morena, Eugenio Montini, Federica Barzaghi, Giulia Consiglieri, Francesca Ferrua, Maddalena Migliavacca, Francesca Tucci, Elena Sophia Fratini, Alessia Ippolito, Paolo Silvani, Maria Rosa Calvi, Alessandra Clerici, Ambra Corti, Marcella Facchini, Sara Locatelli, Mara Sangalli, Stefano Zancan, Federica Miotto, Maria Grazia Natali Sora, Cristina Baldoli, Sabata Martino, Angélica Córdoba-Claros, Sean L. Moro, Nicholas D. Gollop, Jeff Abate, Muska N. Yarzi, Philippa Nutkins, Andrew Shenker, Mattia Calissano, Jean Brooks, Alan Richardson, Laura Campbell, Massimo Filippi, Luigi Naldini, Maria Pia Cicalese, Fabio Ciceri, Maria Ester Bernardo, Alessandro Aiuti
  • Hemiplegic Migraine April 17, 2025
    A 46-year-old woman with a history of migraine with visual aura presented with a 3-hour history of headache, as well as weakness and numbness in the right arm.
    John C. Feemster, Kemar E. Green

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities

Copyright © 2025. RMEI Medical Education, LLC. All rights reserved​

Privacy | Terms of Use